Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VNN1 | O95497 | 4/20 | 0.43 |
| ▸ | PIK3CA | P42336 | 9/20 | 0.42 |
| ▸ | MTOR | P42345 | 3/20 | 0.40 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.40 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.39 |
| ▸ | NAMPT | P43490 | 1/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.37 |
| ▸ | ATR | Q13535 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19623722 | 0.88 | PIK3CA (0.46) | PIK3CAMTORPIK3CBPIK3CG | |
| SCHEMBL12247578 | 0.80 | PIK3CA (0.67) | PIK3CA | |
| Trifluoroacetic Acid SCHEMBL2375870 | 0.76 | PIK3CA (0.61) | PIK3CA | |
| SCHEMBL12247595 | 0.76 | PIK3CA (0.65) | PIK3CAMTOR | |
| SCHEMBL3835911 | 0.76 | PIK3CA (0.72) | PIK3CA | |
| SCHEMBL2377725 | 0.76 | PIK3CA (0.70) | PIK3CA | |
| SCHEMBL19623825 | 0.75 | PIK3CA (0.55) | PIK3CAPIK3CBPIK3CGROCK2 | |
| SCHEMBL19623646 | 0.73 | MTOR (0.48) | PIK3CAMTORPIK3CBPIK3CGATR | |
| SCHEMBL19623809 | 0.72 | PIK3CA (0.52) | PIK3CAPIK3CBPIK3CGNAMPT | |
| Trifluoroacetic Acid SCHEMBL2376933 | 0.72 | PIK3CA (0.59) | PIK3CAMTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2050749-B1 | PYRIMIDINE DERIVATIVE AS PI3K INHIBITOR AND USE THEREOF | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2017-11-22 | — | — | EP | disclosed |